Abstract
Timing of therapy and selection of patients in the use of ventricular assist devices (VADs) can be difficult. In general, consideration for VAD implantation is appropriate in patients with endstage heart failure who are failing optimal medical therapy and in whom no alternative traditional surgical treatment options are available. However, identifying when a particular patient has reached this point is not always straightforward. There are a broad range of medical and surgical therapies for patients with overt heart failure, and this armamentarium is constantly expanding. The risks, benefits, and expected outcomes with VAD therapy have also undergone dramatic changes over the last decade. Advances in technology have led to a proliferation of newer generation devices that are smaller, lighter, easier to implant, and more reliable than previous generation devices. This, in turn, has led to a markedly improved risk–benefit ratio, with increased durability and reduced morbidity. The indications for the implantation of ventricular assist devices have also evolved over the last several years, and specific patient presentations and goals of therapy have led to specific indications. Device therapy has traditionally been classified as bridge to recovery, bridge to transplantation, and destination therapy. However, such designations may not be well defined at the time of implantation, and recovery and response following initiation of VAD support may allow patients to change from one classification to another. The current data regarding indications and timing of device implantation are reviewed.
Similar content being viewed by others
References
Dodrill, F. D., Hill, E., & Gerisch, R. A. (1952). Temporary mechanical substitute for the left ventricle in man. Journal of American Medical Association, 150(7), 642–644.
Gibbon, J. H. (1954). Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota Medicine, 37(3), 171–185, passim.
Liotta, D., Crawford, E. S., Cooley, D. A., Debakey, M. E., De Urquia, M., & Feldman, L. (1962). Prolonged partial left ventricular bypass by means of an intrathoracic pump implanted in the left chest. Transactions—American Society for Artificial Internal Organs, 8, 890–899.
Cooley, D. A., Liotta, D., Hallman, G. L., Bloodwell, R. D., Leachman, R. D., & Milam, J. D. (1969). Orthotopic cardiac prosthesis for two-staged cardiac replacement. American Journal of Cardiology, 24(5), 723–730.
Olsen, D. B., DeVries, W. C., Kolff, J., Frazier, O. H., & Rahimtoola, S. H. (1982). Indeterminate circulatory support with the artificial heart. Transactions—American Society for Artificial Internal Organs, 28, 652–655.
Berson, A. (1988). Ventricular assist systems for temporary life support: device readiness testing. Engineering in Medicine and Biology Magazine, IEEE, 7(2), 92–93.
Schoen, F. J., Palmer, D. C., Bernhard, W. F., Pennington, D. G., Haudenschild, C. C., Ratliff, N. B., et al. (1986). Clinical temporary ventricular assist. Pathologic findings and their implications in a multi-institutional study of 41 patients. Journal of Thoracic and Cardiovascular Surgery, 92(6), 1071–1081.
Farrar, D. J., Lawson, J. H., Litwak, P., & Cederwall, G. (1990). Thoratec VAD system as a bridge to heart transplantation. Journal of Heart Transplantation, 9(4), 415–422, discussion 422-3.
Slaughter, M. S., Tsui, S. S., El-Banayosy, A., Sun, B. C., Kormos, R. L., Mueller, D. K., et al. (2007). Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. The Journal of Thoracic and Cardiovascular Surgery, 133(6), 1573–1580, e2.
Frazier, O. H., Rose, E. A., Oz, M. C., Dembitsky, W., McCarthy, P., Radovancevic, B., et al. (2001). Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. Journal of Thoracic and Cardiovascular Surgery, 122(6), 1186–1195.
Rose, E. A., Gelijns, A. C., Moskowitz, A. J., Heitjan, D. F., Stevenson, L. W., Dembitsky, W., et al. (2001). The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure. New England Journal of Medicine, 345(20), 1435–1443.
Pagani, F. D., Long, J. W., Dembitsky, W. P., Joyce, L. D., & Miller, L. W. (2006). Improved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist System. Annals of Thoracic Surgery, 82(4), 1413–1418.
Starnes, V. A., Oyer, P. E., Portner, P. M., Ramasamy, N., Miller, P. J., Stinson, E. B., et al. (1988). Isolated left ventricular assist as bridge to cardiac transplantation. Journal of Thoracic and Cardiovascular Surgery, 96(1), 62–71.
Dagenais, F., Portner, P. M., Robbins, R. C., & Oyer, P. E. (2001). The Novacor left ventricular assist system: clinical experience from the Novacor registry. Journal of Cardiac Surgery, 16(4), 267–71.
Rogers, J. G., Butler, J., Lansman, S. L., Gass, A., Portner, P. M., Pasque, M. K., et al. (2007). Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID Trial. Journal of the American College of Cardiology, 50(8), 741–747.
Ratner, B. D., Hoffman, A. S., Schoen, F. J., & Lemons, J. E. (2004). Biomaterials Science. Orlando: Elsevier.
Radovancevic, B., Vrtovec, B., de Kort, E., Radovancevic, R., Gregoric, I. D., & Frazier, O. (2007). End-organ Function in Patients on Long-term Circulatory Support With Continuous- or Pulsatile-flow Assist Devices. The Journal of Heart and Lung Transplantation, 26(8), 815–818.
John, R. (2008). Current Axial-Flow Devices–the HeartMate II and Jarvik 2000 Left Ventricular Assist Devices. Seminars in Thoracic and Cardiovascular Surgery, 20(3), 264–272.
Miller, L. W., Pagani, F. D., Russell, S. D., John, R., Boyle, A. J., Aaronson, K. D., et al. (2007). The HeartMate II Clinical Investigators. Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation. New England Journal of Medicine, 357(9), 885–896.
Pagani, F. D. (2008). Continuous-Flow Rotary Left Ventricular Assist Devices with “3rd Generation” Design. Seminars in Thoracic and Cardiovascular Surgery, 20(3), 255–263.
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation, 112(12), e154–e235.
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., et al. (2008). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure, 10(10), 933–989.
Kirklin, J. K., Naftel, D. C., Stevenson, L. W., Kormos, R. L., Pagani, F. D., Miller, M. A., et al. (2008). INTERMACS Database for Durable Devices for Circulatory Support: First Annual Report. The Journal of Heart and Lung Transplantation, 27(10), 1065–1072.
Aaronson, K. D., Schwartz, J. S., Chen, T., Wong, K., Goin, J. E., & Mancini, D. M. (1997). Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation. Circulation, 95(12), 2660–2667.
Mehra, M. R., Kobashigawa, J., Starling, R., Russell, S., Uber, P. A., Parameshwar, J., et al. (2006). Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates–2006. The Journal of Heart and Lung Transplantation, 25(9), 1024–1042.
Koelling, T. M., Joseph, S., & Aaronson, K. D. (2004). Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving [beta]-blockers. The Journal of Heart and Lung Transplantation, 23(12), 1414–1422.
Lund, L. H., Aaronson, K. D., & Mancini, D. M. (2005). Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. The American Journal of Cardiology, 95(6), 734–741.
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., et al. (2006). The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation, 113(11), 1424–1433.
Huang, R., Deng, M., Rogers, J., Howser, R., Portner, P., Pierson, R. III, et al. (2006). Effect of Age on Outcomes After Left Ventricular Assist Device Placement. Transplantation Proceedings, 38(5), 1496–1498.
Hernandez, A. F., Shea, A. M., Milano, C. A., Rogers, J. G., Hammill, B. G., O, , Connor, C. M., et al. (2008). Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries. Journal of the American Medical Association, 300(20), 2398–2406.
Holman, W. L., Kormos, R. L., Naftel, D. C., Miller, M. A., Pagani, F. D., Blume, E., et al. (2009). Predictors of Death and Transplant in Patients With a Mechanical Circulatory Support Device: A Multi-institutional Study. The Journal of Heart and Lung Transplantation, 28(1), 44–50.
Butler, J., Howser, R., Portner, P. M., & Pierson, R. N. (2005). Body Mass Index and Outcomes After Left Ventricular Assist Device Placement. The Annals of Thoracic Surgery, 79(1), 66–73.
Taylor, D. O., Edwards, L. B., Aurora, P., Christie, J. D., Dobbels, F., Kirk, R., et al. (2008). Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Heart Transplant Report–2008. The Journal of Heart and Lung Transplantation, 27(9), 943–956.
Oz, M. C., Goldstein, D. J., Pepino, P., Weinberg, A. D., Thompson, S. M., Catanese, K. A., et al. (1995). Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation, 92(9 Suppl), II169–II173.
Rao, V., Oz, M. C., Flannery, M. A., Catanese, K. A., Argenziano, M., & Naka, Y. (2003). Revised screening scale to predict survival after insertion of a left ventricular assist device. Journal of Thoracic and Cardiovascular Surgery, 125(4), 855–862.
Lietz, K., Long, J. W., Kfoury, A. G., Slaughter, M. S., Silver, M. A., Milano, C. A., et al. (2007). Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection. Circulation, 116(5), 497–505.
Fukamachi, K., McCarthy, P. M., Smedira, N. G., Vargo, R. L., Starling, R. C., & Young, J. B. (1999). Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. The Annals of Thoracic Surgery, 68(6), 2181–2184.
Nakatani, S., Thomas, J. D., Savage, R. M., Vargo, R. L., Smedira, N. G., & McCarthy, P. M. (1996). Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation, 94(9 Suppl), II216–II221.
Fitzpatrick, J. R., Frederick, J. R., Hsu, V. M., Kozin, E. D., O, , Hara, M. L., Howell, E., et al. (2008). Risk Score Derived from Pre-operative Data Analysis Predicts the Need for Biventricular Mechanical Circulatory Support. The Journal of Heart and Lung Transplantation, 27(12), 1286–1292.
Ochiai, Y., McCarthy, P. M., Smedira, N. G., Banbury, M. K., Navia, J. L., Feng, J., et al. (2002). Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients. Circulation, 106(90121), I–198-I-202.
Matthews, J. C., Koelling, T. M., Pagani, F. D., & Aaronson, K. D. (2008). The Right Ventricular Failure Risk Score: A Pre-Operative Tool for Assessing the Risk of Right Ventricular Failure in Left Ventricular Assist Device Candidates. Journal of the American College of Cardiology, 51(22), 2163–2172.
Puwanant, S., Hamilton, K. K., Klodell, C. T., Hill, J. A., Schofield, R. S., Cleeton, T. S., et al. (2008). Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. Journal of Heart and Lung Transplantation, 27(10), 1102–1107.
Zimpfer, D., Zrunek, P., Roethy, W., Czerny, M., Schima, H., Huber, L., et al. (2007). Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. Journal of Thoracic and Cardiovascular Surgery, 133(3), 689–695.
Assad-Kottner, C., Chen, D., Jahanyar, J., Cordova, F., Summers, N., Loebe, M., et al. (2008). The Use of Continuous Milrinone Therapy as Bridge to Transplant Is Safe in Patients With Short Waiting Times. Journal of Cardiac Failure, 14(10), 839–843.
Gronda, E., Bourge, R. C., Costanzo, M. R., Deng, M., Mancini, D., Martinelli, L., et al. (2006). Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates–2006. The Journal of Heart and Lung Transplantation, 25(9), 1043–1056.
Rossinen, J., Harjola, V., Siirila-Waris, K., Lassus, J., Melin, J., Peuhkurinen, K., & Nieminen, M. S. (2008). The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study. Acute Card Care, 10(4), 209–213.
Stevenson, L. W., Miller, L. W., Desvigne-Nickens, P., Ascheim, D. D., Parides, M. K., Renlund, D. G., et al. (2004). Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation, 110(8), 975–981.
Aaronson, K. D., Patel, H., & Pagani, F. D. (2003). Patient selection for left ventricular assist device therapy. The Annals of Thoracic Surgery, 75(6, Supplement 1), S29–S35.
Birks, E. J., Tansley, P. D., Hardy, J., George, R. S., Bowles, C. T., Burke, M., et al. (2006). Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure. New England Journal of Medicine, 355(18), 1873–1884.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, D.G., Oyer, P.E. & Mallidi, H.R. Ventricular Assist Devices: History, Patient Selection, and Timing of Therapy. J. of Cardiovasc. Trans. Res. 2, 159–167 (2009). https://doi.org/10.1007/s12265-009-9098-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9098-5